A detailed history of Central Pacific Bank Trust Division transactions in Argenx Se stock. As of the latest transaction made, Central Pacific Bank Trust Division holds 1,264 shares of ARGX stock, worth $1.15 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
1,264
Previous 1,278 1.1%
Holding current value
$1.15 Million
Previous $704 Million 32.34%
% of portfolio
0.11%
Previous 0.09%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 02, 2025

SELL
$538.64 - $768.0 $7,540 - $10,752
-14 Reduced 1.1%
1,264 $932 Million
Q2 2025

Jul 01, 2025

BUY
$532.27 - $656.65 $15,968 - $19,699
30 Added 2.4%
1,278 $704 Million
Q1 2025

Apr 03, 2025

BUY
$571.0 - $671.75 $141,608 - $166,594
248 Added 24.8%
1,248 $739 Million
Q4 2024

Jan 03, 2025

BUY
$520.52 - $638.33 $520,520 - $638,330
1,000 New
1,000 $615 Million
Q1 2024

May 02, 2024

BUY
$356.95 - $413.29 $281,633 - $326,085
789 New
789 $313 Million

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $50.2B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Central Pacific Bank Trust Division Portfolio

Follow Central Pacific Bank Trust Division and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Pacific Bank Trust Division, based on Form 13F filings with the SEC.

News

Stay updated on Central Pacific Bank Trust Division with notifications on news.